Pharmacogenetics has evolved over the past few years into pharmacogenomics, shifting focus from individual candidate genes to genome-wide association studies. The latest installment in our Genomic Medicine series, Genomics and Drug Response, reviews recent pharmacogenetic and pharmacogenomic advances, and discusses how such advances are reflected in drug labels. The authors aim to provide assurance that advances resulting from the application of genomic science to drug therapy may assist with drug selection and dosing, and reduce the odds of adverse drug reactions. Earlier articles in this series include Genomics and the Continuum of Cancer Care — NEJM, Genomics, Type 2 Diabetes, and Obesity, Ancestry and Disease in the Age of Genomic Medicine, New Therapeutic Approaches to Mendelian Disorders, Genomewide Association Studies and Assessment of the Risk of Disease, Genomic Medicine — An Updated Primer.
Comments are closed.
Get Our Blog Updates Via E-mail!
NEJM in the News
- NPR Shots covered the NEJM Original Article, “Prevalence of Pulmonary Embolism among Patients Hospitalized for Syncope.” (October 20)
- Politico Pulse included the NEJM Perspective, “Trouble on the Exchanges — Does the United States Owe Billions to Health Insurers?” (October 20)
- STAT On Call included the NEJM Perspective, “Effect of Medicaid Coverage on ED Use — Further Evidence from Oregon’s Experiment.” Politico Pulse also included the article. (October 20)
- Vox referenced the 2010 NEJM Perspective, “Why We Don’t Spend Enough on Public Health,” in a story titled, “America’s view of “health” is very narrow. The debates proved it.” (October 20)
- STAT Morning Rounds referenced the NEJM Perspective, “The United States and Cuba — Turning Enemies into Partners for Health,” writing that Health and Human Services Secretary Sylvia Burwell heads to Cuba today to talk Zika efforts and international health issues, and that the visit coincides with the NEJM article, penned by public health expert Dr. C. William Keck, analyzing the budding relationship between the two health care systems. (October 20)
- NPR Shots/All Things Considered/Oregon Public Broadcasting covered the NEJM Perspective, “Effect of Medicaid Coverage on ED Use — Further Evidence from Oregon’s Experiment.” KHN ran the story. (October 19)
NEJM on Youtube
- NEJM Group will be exhibiting at the upcoming conferences below:
- European Society of Cardiology in London, England. Aug. 29-Sept. 2. Booth #C-807
- IDWeek in San Diego, CA. Oct. 8-10. Booth #922
- American Society of Nephrology in San Diego, CA. Nov. 5-7. Booth #508
- American Heart Association in Orlando, FL. Nov. 8-10. Booth #822
- American Society of Hematology in Orlando, FL. Dec. 5-7. Booth #514
Tagsabdominal pain anemia asthma breast cancer cancer cardiac arrest Case Records Case Records of the Massachusetts General Hospital chemotherapy Clinical Decisions Clinical Practice Clinical Problem-Solving colorectal cancer COPD CPR Diabetes dyspnea emergency medicine fever global health glucocorticoids HIV hypertension Interactive Medical Cases Massachusetts General Hospital medicine myocardial infarction NEJM nejm 200th anniversary NEJM 200th Anniversary website NEJM Group NEJM Group Open Forum New England Journal of Medicine obesity pregnancy primary care/hospitalist/clinical practice prostate cancer septic shock smoking stroke surgery thrombocytopenia tuberculosis type 2 diabetes Venous thromboembolism